Article
Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues.
British journal of cancer - 1 May 1999
Leygue E, Dotzlaw H, Watson P H, Murphy L C
Abstract excerpt
The progesterone receptor (PR) is an important prognostic marker in breast cancer as well as a marker of responsiveness to endocrine therapies. The presence of several exon-deleted PR variant mRNAs in both normal and neoplastic breast samples has recently been reported. Amongst them, a variant mRNA deleted in exon 6 (D6-PR mRNA) that if translated would encode a truncated PR-like protein missing the hormone...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
